US FDA approves GSK's urinary tract infection drug
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
Medpage Today on MSN8h
FDA OKs New Option for Uncomplicated UTIs in Women, Girls
The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 ...
The American Journal of Managed Care8h
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
Fierce Pharma9h
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
Benzinga.com3d
Best Stocks Under $50
Invest in the best stocks under $50 with Interactive Brokers for fast trade execution. You don’t need thousands of dollars in the bank to get started investing. Just $50, or less, can help you ...
Indiatimes4d
Nifty Midcap 50
What does Nifty Midcap 50 represent? Represents the mid-cap segment of the Indian equity market, comprising 50 mid-sized companies listed on the National Stock Exchange (NSE), providing insights into ...
moneycontrol.com5d
ICICI Prudential Nifty Next 50 Index Fund - Growth
Fund manager updated portfolio more frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for shorter duration than peers) ...